Minocycline;Minocycline

Annales de Dermatologie et de Venereologie

Volumn 128, Issue 5, 2001, Pages 627-637

  Bernier, C ^a   Dreno B ^a  

^a CLINIQUE DERMATOLOGIQUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MINOCYCLINE;

ACNE; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; AUTOIMMUNE HEPATITIS; BULLOUS SKIN DISEASE; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG INDICATION; HUMAN; LEPROSY; LIPOPHILICITY; LUPUS VULGARIS; LYME DISEASE; MYCOBACTERIOSIS; NOCARDIOSIS; PIGMENT DISORDER; PRURIGO; PYODERMA GANGRENOSUM; SEXUALLY TRANSMITTED DISEASE; VERTIGO;

ACNE VULGARIS; ANTI-BACTERIAL AGENTS; AUTOIMMUNE DISEASES; CYTOKINES; DRUG ADMINISTRATION SCHEDULE; HUMANS; LEPROSY; LYME DISEASE; MINOCYCLINE; MYCOBACTERIUM INFECTIONS; NOCARDIA INFECTIONS; PRURIGO; PYODERMA GANGRENOSUM; RESEARCH DESIGN; SEXUALLY TRANSMITTED DISEASES; SKIN DISEASES, VESICULOBULLOUS; TREATMENT OUTCOME;

EID: 0034950524     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. In vitro modulation of epidermal inflammatory cytokines (alpha, IL-6, TNF alpha) by minocycline
2. Minocycline modulation of alpha-MSH production by keratinocytes in vitro
3. Modulation of comedonal levels of interleukin-1 in acne pat treated with tetracyclines
4. The influence of tetracyclines on T cell activation
5. Tetracycline up-regulates COX-2 expression and prostaglandine production independent of its effect on nitric oxide
6. Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells
7. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease
8. The effect of minocycline on the metabolism of androgens by human oral periosteal fibroblasts and its inhibition by finasteride
9. Short-term toxicity and observations on certain aspects of the pharmacology of a unique Tétracycline: Minocycline
10. Evaluation of the hepatotoxic potential of minocycline
11. Morphological and biochimical studies on minocycline-induced black thyroid in rats
12. La minocycline
13. Clinical pharmacokinetics of doxycycline and minocycline
14. Minocycline compared with doxycycline in the treatment of nongonococcal urethritis and mucopurulent cervicitis
15. Effect of short term treatment of non-gonococcal urethritis minocycline
16. Tetracycline and minocycline in the management of non-gonurethritis: A comparison
17. Comparison of tetracycline and minocycline in the treatment of non gonococcal urethritis
18. Minocycline for acne vulgaris: Efficacy and safety
19. Primary cutaneous nocardiosis
20. Erythema migrans: Three weeks treatment for prevention of late Lyme borreliosis
21. WHO expert Committee on Leprosy
22. Prurigo pigmentosa successfully treated with minocycline
23. Combination therapy with nicotinamide and tetracyclines for cicatricial pemphigoid: Further support for its efficacy
24. Minocycline is a useful adjuvant therapy for pemphigus
25. Minocycline treatment for confluent and reticulated papillomatosis
26. Superficial granulonnatous pyoderma: A localized vegetative form of pyoderma gangrenosum
27. Streptococcal infection in the pathogenersis of Bebcet's disease and clinical effects of monocycline on the diseade symptoms
28. Comparative safety of tetracycline, minocycline, and doxycycline
29. Safety of long-term high-dose minocycline in the treatment of acne
30. Minocycline and benign intracranial hypertension
31. Acute hepatitis and exfoliative dermatitis associated with minocycline
32. Minocycline-induced pigmentation. Incidence, prevention and management
33. Minocycline-induced oral hyperpigmentation
34. Hyperpigmentation of the skin associated with minocycline therapy
35. Minocycline-related hyperpigmentation
36. Black galactorrhea as a consequence of minocycline and phenothiazine therapy
37. Minocycline-induced lupus
38. Réactions systémiques secondaires à la prise de minocycline. A propos de quatre observations et revue de la littérature
39. Minocycline and lupus like syndrome in acne patients
40. Comparative safety of tetracycline, minocycline, and doxycycline
41. Minocycline-related auto-immune hépatitis: Case series and literature review
42. Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome
43. Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature
44. Syndrome d'hypersensibilité à la minocycline: 7 cas
45. Pneumopathie à la minocycline
46. Minocycline-induced cell-mediated hypersensitivity pneumonitis
47. Protacted systemic illness and interstitial nephritis due to minocycline
48. Pseudo-maladie sérique après prise de minocycline
49. Acute febrile neutrophilic dermatosis (Sweet's syndrome) caused by minocycline
50. Minocycline-induced Sweet's syndrome
51. Syndrome de Sweet induit par la minocycline
52. Anaphylactoid symptoms due to oral minocycline
53. Complications of minocycline therapy for acne vulgaris: Case reports and review of the literature